4//SEC Filing
Sjuts Dustin S 4
Accession 0001479290-23-000002
CIK 0001479290other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:28 PM ET
Size
4.8 KB
Accession
0001479290-23-000002
Insider Transaction Report
Form 4
Sjuts Dustin S
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-12-31$12.18/sh+605$7,369→ 95,812 total
Footnotes (1)
- [F1]These shares were acquired by Mr. Sjuts under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2022 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001796224
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:28 PM ET
- Size
- 4.8 KB